Lung lever after COVID-19: clinical-X-ray, surgical and morphological characteristics
MATERIALS AND METHODS. Preliminary clinical and morphological analysis of a group of patients with various post-COVID complications and with surgical treatment was performed. For the period 2020-2021 in the clinic of thoracic surgery of the SI “National institute of phthisiology and pulmonology named after F.G. Yanovsky of the NAMS of Ukraine” 12 patients were treated who had coronavirus disease (COVID-19) in anamnesis and underwent surgery for COVID-19 complications.
RESULTS AND DISCUSSION. Data on the type of surgery, X-ray conclusion and preliminary clinical diagnoses of patients with post-COVID pulmonary complications are presented. At the time of surgical treatment, according to clinical data, 4 (22.2 %) patients were diagnosed with lung abscess, 4 (22.2 %) patients had a disseminated process in the lungs of unclear origin, 2 (11.0 %) – a solitary formation of the lung, one (5.5 %, respectively) observation – spontaneous pneumothorax and suspected tumor of the lung. The results of the histopathological conclusion on the operative material and the final clinical diagnosis in the group of patients with atypical lung lesions after COVID-19 are presented. The results of histopathological examination showed that after 3 months and more after recovery from COVID-19 in some patients there are persistent pathological changes in lung tissue of various characters, and quantitatively among them prevail cases of various pathologies associated with damage to the vascular bed of the lungs.
CONCLUSIONS. In most cases of pulmonary complications after suffering COVID-19, preliminary clinical diagnoses did not fully correspond to the identified pathological process. Morphological examination of the operative material of patients with a history of COVID-19 and postcocious complications associated with the lungs, found that vascular pulmonary pathology predominates: persistent microvasculitis of small blood vessels, pulmonary infarction, metacarpal metaplasia, secondary vascular malformation.
Lake M.A. What we know so far: COVID-19 current clinical knowledge and research. Clin. Med. 2020 Mar 5; 20 (2): 124-7.
Mohanty S.K., Satapathy A., Naidu M.M., Mukhopadhyay S., Sharma Sh., et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge. Diagnostic Pathology. 2020 Aug 14; 15 (1): 103. doi: 10.1186/s13000-020-01017-8.
Coronavirus Resource Center. Mortality Analyses [Internet]. Johns Hopkins University. 2020 Nov 24. Available at: https://coronavirus.jhu.edu/data/mortality.
Deshmukh V., Motwani R., Kumar A., Kumari C., Raza K., et al. Histopathological observations in COVID-19: a systematic review. J. Clin. Pathol. 2021 Feb; 74 (2): 76-83. doi: 10.1136/jclinpath-2020-206995.
Higgins V., Sohaei D., Diamandis E.P., Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Critical Reviews in Clinical Laboratory Sciences. 2021 Aug; 58 (5): 297-310. doi: 10.1080/10408363.2020.1860895.
Cao Y., Liu X., Xiong L., et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J. Med. Virol. 2020 Sep; 92 (9): 1449-1459. doi: 10.1002/jmv.25822.
Shi H., Han X., Jiang N., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 2020 Apr; 20 (4): 425-434. doi: 10.1016/S1473-3099(20)30086-4.
Spagnolo P., Balestro E., Aliberti S., et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir. Med. 2020 Aug; 8 (8): 750-752. doi: 10.1016/S2213-2600(20)30222-8.
Aiolfi A., Biraghi T., Montisci A., Bonitta G., Micheletto G., Donatelli F., et al. Management of persistent pneumothorax with thoracoscopy and bleb resection in COVID-19 patients. Ann. Thorac. Surg. 2020 Nov; 110 (5): 413-415. doi: 10.1016/j.athoracsur.2020.04.011.
Pieracci F.M., et al. Tube thoracostomy during the COVID-19 pandemic: guidance and recommendations from the AAST Acute Care Surgery and Critical Care Committees. Trauma Surg. Acute Care Open. 2020; 1: 498. doi: 10.1136/tsaco-2020-000498 11.
Sushko A.A., Prokopchik N.I., Kropa Yu.S. Possibilities of diagnostics and surgical treatment of complications of viral lung injury in COVID-19. Journal of Grodno State Medical University. 2021; 19 (1): 112-118. doi: 10.25298/2221-8785-2021-19-1-112-118.
Zaikov SV Treatment of patients with COVID-19: clinical trials and guidelines in different countries. Infusion & Chemotherapy. 2020; 4: 5-12. doi: 10.32902/2663-0338-2020-4-5-12.
Guzik T.J., Mohiddin S.A., Dimarco A., et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020 Aug 1; 116 (10): 1666-1687. doi: 10.1093/cvr/cvaa106.
Zairatyants O.V., Samsonova M.V., Mikhaleva L.M., Chernyaev A.L., Mishnev O.D., Krupnov N.M. et al. Under the general editorship. O.V. Zairatyants. Pathological anatomy COVID-19. Atlas. – M.: DZM, 2020. – 116 с.
Katzenstein A.A., Askin F.B. Surgical pathology of non-neoplastic lung disease. Major Probl. Pathol. 1982; 13: 1-430.
Ni L., Ye F., Cheng Y., Feng Y., Deng Q., Zhao H., et al. Detection of SARS-CoV-2- specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020 June; 52: 971-977. doi: 10.1016/j.immuni.2020.04.023.
Myall K.J., Mukherjee B., Castanheira A.M., Lam J.L., Benedetti G., Mak S.M., et al. Persistent post-COVID-19 interstitial lung disease. Ann. Am. Thorac. Soc. 2021 May 5; 799-806. doi: 10.1513/AnnalsATS.202008-1002OC.
McDonald L.T. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? J. Physiol. Lung Cell Mol. Physiol. 2021 Feb 1; 320 (2): L257-L265. doi: 10.1152/ajplung.00238.2020.
Toshiaki Iba, Connors J.M., Levy J.H. The coagulopathy, endotheliopathy and vasculitis of COVID-19. Inflammation Research. 2020 Dec; 69 (12): 1181-1189. doi: 10.1007/s00011-020-01401-6.
Long Q.X., Tang X.J., Shi Q.L., et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 2020 Aug; 26 (8): 1200-1204. doi: 10.1038/s41591-020-0965-6.
Peiris S., Mesa H., Aysola A., Manivel J., Toledo J., Borges-Sa M., et al. Pathological findings in organs and tissues of patients with COVID-19: a systematic review. PLoS One. 2021 Apr 28; 16 (4): e0250708. doi: 10.1371/journal.pone.0250708.
Solomon J.J., Heyman B., Ko J.P., Condos R., Lynch D.A. CT of postacute lung complications of COVID-19. Radiology. 2021 Nov; 301 (2): E383-E395. doi: 10.1148/radiol.2021211396. Epub 2021 Aug 10.
Opanasenko M.S., Konik B.M., Bilokon S.M., Tereshkovich O.V., Shalagay S.M., Levanda L.I. that in. Treatment of bronchogenetic purulent-inflammatory conditions due to the transferred coronavirus infection: the first report. Tuberculosis. Lung Diseases. HIV. 2021; 3 (46).
Opanasenko MS, Konik BM, Bilokon SM, Tereshkovich OV, Shalagai SM, Levanda L.I. et al. Surgical treatment of thoracic pathology in patients with coronavirus infection. Ukrainian Pulmonology Journal.2021; 3: 31-35. doi: 10.31215/2306-4927-2021-29-3-31-35.
This work is licensed under a Creative Commons Attribution 4.0 International License.